What’s new in IUGR from the endocrinological point of view?

Alicja Korpysz; Mieczysław Szalecki

doi:10.5114/pedm.2019.91547

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Journal integrated with

4/2019
vol. 25

Send email

Copy url:

abstract:

Review paper

What’s new in IUGR from the endocrinological point of view?

Alicja Korpysz

¹

,

Mieczysław Szalecki

²

Outpatient Clinic of Endocrinology and Diabetology, Children’s Memorial Health Institute, Warsaw, Poland

Department of Endocrinology and Diabetology, Children’s Memorial Health Institute, Warsaw, Poland

Pediatr Endocrinol Diabetes Metab 2019; 25 (4): 188-193

DOI: https://doi.org/10.5114/pedm.2019.91547

Online publish date: 2019/12/30

View full text Get citation

PlumX metrics:

Genetic causes of IUGR: The IGF 2 gene encoding IGF2 synthesis contributes to growth of the foetus. The maternal genes PHLDA2, GRB10, and placental ALS also play a role in the regulation of foetal growth. CDKN1C mutation can lead to IUGR. In SRS syndrome, apart from epimutation 11p15 and disomy 7, the cause may be a mutation of HMAGA2-PLAG1-IGF2 genes. Growth deficiency: in 10% of children with IUGR with growth deficiency, ACAN gene mutation (aggrecan gene) was described. Children with IUGR and with dynamic evolution of puberty can achieve better final growth through combined therapy with GH and GnRH analogues. Insulin resistance: In light of new reports, oxidative stress during pregnancy, epigenetic regulation in the foetal period in children with IUGR, and insulin resistance both peripheral and central during catch up growth” are observed.

keywords:

What’s new in IUGR from the endocrinological point of view?

Alicja Korpysz 1 , Mieczysław Szalecki 2

IUGR, growth deficit, insulin resistance

Alicja Korpysz

¹

,

Mieczysław Szalecki

²